Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Large Insider Purchases

Institutional-Scale SEC Form 4 Buy Signals

The Signal of $1M+ Conviction

When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.

Filing Date Trade Date Ticker Company Name Reporting Person Relationship Industry Type Price Qty Total, $ Owned After Change, %
2017-10-24 00:43 2017-10-19 CNCE N/A BVF PARTNERS L P/IL 10% owner Other BUY $15.84 331,916 $5,256,720 291,788 +100.0%
2017-10-23 23:48 2017-10-20 PAG PENSKE AUTOMOTIVE GROUP, INC. PENSKE ROGER S Director, Officer, 10% owner - Chairman & CEO Retail-Auto Dealers & Gasoline Stations BUY $45.29 1,103,996 $49,999,979 33,688,936 +3.4%
2017-10-23 23:48 2017-10-20 PAG PENSKE AUTOMOTIVE GROUP, INC. PENSKE CORP 10% owner Retail-Auto Dealers & Gasoline Stations BUY $45.29 1,103,996 $49,999,979 33,688,936 +3.4%
2017-10-20 00:48 2017-10-16 STQN STRATEGIC ACQUISITIONS INC /NV/ NextCoal International, Inc. 10% owner Finance Services BUY $300,000.00 750,000 $225,000,000,000 1,625,000 +85.7%
2017-10-20 03:43 2017-10-17 XNAFX N/A Colony NorthStar, Inc. 10% owner Other BUY $9.04 119,115 $1,076,800 2,161,674 +5.8%
2017-10-19 23:52 2017-10-18 DVMT Dell Technologies Inc. DELL MICHAEL S Director, Officer - Chief Executive Officer Electronic Computers BUY $32.70 81,573 $2,667,437 499,604 +19.5%
2017-10-20 03:29 2017-10-12 KALV KalVista Pharmaceuticals, Inc. ALDRICH RICHARD Director Pharmaceutical Preparations BUY $8.61 565,065 $4,866,961 934,484 +153.0%
2017-10-18 23:53 2017-10-16 CCUR N/A SINGER JULIAN D. 10% owner Other BUY $6.24 286,040 $1,786,091 1,708,419 +20.1%
2017-10-18 23:37 2017-10-16 PWON N/A LU JOSEPH Director, Officer, 10% owner - CEO Other BUY $0.75 4,077,573 $3,074,490 19,897,830 +25.8%
2017-10-18 23:35 2017-10-16 PWON N/A Zhu Xiao Yin 10% owner Other BUY $0.75 4,077,573 $3,074,490 7,608,353 +115.5%
2017-10-19 00:34 2017-10-16 N/A N/A BROADWOOD PARTNERS, L.P. Other Other BUY $2.60 1,592,308 $4,140,001 5,292,156 +43.0%
2017-10-18 22:00 2017-10-16 AXDX N/A SCHULER JACK W Director, 10% owner Other BUY $20.07 59,922 $1,202,635 12,981,867 +0.5%
2017-10-18 00:58 2017-10-13 BTX Lineage Cell Therapeutics, Inc. BROADWOOD PARTNERS, L.P. Director, 10% owner Biological Products, (No Diagnostic Substances) BUY $2.60 2,692,307 $6,999,998 29,971,561 +9.9%
2017-10-17 22:00 2017-10-13 AXDX N/A SCHULER JACK W Director, 10% owner Other BUY $19.29 61,300 $1,182,226 12,954,005 +0.5%
2017-10-18 00:01 2017-10-16 IMH IMPAC MORTGAGE HOLDINGS INC RHP Trust, dated May 31, 2011 10% owner Real Estate Investment Trusts BUY $12.25 300,000 $3,675,000 2,660,465 +12.7%
2017-10-18 00:00 2017-10-16 IMH IMPAC MORTGAGE HOLDINGS INC Gamebusters, Inc. 10% owner Real Estate Investment Trusts BUY $12.25 194,004 $2,376,549 1,385,157 +16.3%
2017-10-18 00:00 2017-10-16 IMH IMPAC MORTGAGE HOLDINGS INC PICKUP RICHARD H/ 10% owner Real Estate Investment Trusts BUY $12.25 494,004 $6,051,549 1,385,157 +55.4%
2017-10-16 23:31 2017-10-12 KALV KalVista Pharmaceuticals, Inc. Shah Rajeev M. Director, 10% owner Pharmaceutical Preparations BUY $8.50 850,000 $7,225,000 1,441,070 +143.8%
2017-10-16 23:32 2017-10-12 KALV KalVista Pharmaceuticals, Inc. RA CAPITAL MANAGEMENT, LLC Director, 10% owner Pharmaceutical Preparations BUY $8.50 850,000 $7,225,000 1,441,070 +143.8%
2017-10-17 03:11 2017-10-12 IIPR INNOVATIVE INDUSTRIAL PROPERTIES INC Gold Alan D Director, Officer - Executive Chairman Real Estate BUY $25.00 80,000 $2,000,000 80,000 +100.0%
2017-10-17 03:08 2017-10-12 IIPR INNOVATIVE INDUSTRIAL PROPERTIES INC Kreitzer Gary A Director Real Estate BUY $25.00 40,000 $1,000,000 40,000 +100.0%
2017-10-17 00:48 2017-10-12 MB N/A Luxor Capital Group, LP 10% owner Other BUY $27.95 83,022 $2,320,374 498,724 +20.0%
2017-10-16 18:34 2017-10-12 PZG Paramount Gold Nevada Corp. FCMI Parent Co. 10% owner Metal Mining BUY $1.40 1,075,000 $1,505,000 4,347,910 +32.8%
2017-10-16 23:16 2017-10-12 ULTA Ulta Beauty, Inc. HEILBRONN CHARLES Director Retail-Retail Stores, NEC BUY $195.21 127,889 $24,965,838 2,230,252 +6.1%
2017-10-17 00:57 2017-10-12 CONN N/A STEPHENS HARRIET C 10% owner Other BUY $25.40 42,000 $1,066,800 2,769,920 +1.5%
2017-10-17 00:58 2017-10-12 CONN N/A STEPHENS WARREN A 10% owner Other BUY $25.40 42,000 $1,066,800 2,769,920 +1.5%
2017-10-16 22:06 2017-10-12 AXDX N/A SCHULER JACK W Director, 10% owner Other BUY $19.74 276,200 $5,452,188 12,892,705 +2.2%
2017-10-14 00:14 2017-10-11 GSAT Globalstar, Inc. Monroe James III Director, Officer, 10% owner - Chief Executive Officer Communications Services, NEC BUY $1.57 27,607,656 $43,275,001 669,552,891 +4.3%
2017-10-13 17:30 2017-10-11 AXDX N/A SCHULER JACK W Director, 10% owner Other BUY $20.27 51,600 $1,045,932 12,616,505 +0.4%
2017-10-11 23:12 2017-10-11 SWCH N/A Morton Erin Thomas Officer, 10% owner - President and General Counsel Other BUY $17.00 300,000 $5,100,000 300,000 +100.0%
2017-10-11 21:24 2017-10-10 RYTM RHYTHM PHARMACEUTICALS, INC. Foley Todd Director, 10% owner Pharmaceutical Preparations BUY $17.00 100,000 $1,700,000 2,696,392 +3.9%
2017-10-11 23:00 2017-10-06 MERC MERCER INTERNATIONAL INC. KELLOGG PETER R 10% owner Pulp Mills BUY $12.41 2,658,743 $33,000,052 2,000,000 +100.0%
2017-10-11 21:25 2017-10-10 RYTM RHYTHM PHARMACEUTICALS, INC. MPM BIOVENTURES V, L.P. 10% owner Pharmaceutical Preparations BUY $17.00 100,000 $1,700,000 2,696,392 +3.9%
2017-10-10 23:36 2017-10-10 RYTM RHYTHM PHARMACEUTICALS, INC. Viswanathan Ravi 10% owner Pharmaceutical Preparations BUY $17.00 550,000 $9,350,000 4,909,956 +12.6%
2017-10-10 23:32 2017-10-10 RYTM RHYTHM PHARMACEUTICALS, INC. NEW ENTERPRISE ASSOCIATES 13 LP 10% owner Pharmaceutical Preparations BUY $17.00 550,000 $9,350,000 4,909,956 +12.6%
2017-10-10 23:34 2017-10-10 RYTM RHYTHM PHARMACEUTICALS, INC. BASKETT FOREST 10% owner Pharmaceutical Preparations BUY $17.00 550,000 $9,350,000 4,909,956 +12.6%
2017-10-10 23:35 2017-10-10 RYTM RHYTHM PHARMACEUTICALS, INC. SANDELL SCOTT D 10% owner Pharmaceutical Preparations BUY $17.00 550,000 $9,350,000 4,909,956 +12.6%
2017-10-10 23:34 2017-10-10 RYTM RHYTHM PHARMACEUTICALS, INC. KERINS PATRICK J 10% owner Pharmaceutical Preparations BUY $17.00 550,000 $9,350,000 4,909,956 +12.6%
2017-10-10 23:35 2017-10-10 RYTM RHYTHM PHARMACEUTICALS, INC. MOTT DAVID M 10% owner Pharmaceutical Preparations BUY $17.00 550,000 $9,350,000 4,909,956 +12.6%
2017-10-10 23:33 2017-10-10 RYTM RHYTHM PHARMACEUTICALS, INC. BARRETT M JAMES 10% owner Pharmaceutical Preparations BUY $17.00 550,000 $9,350,000 4,909,956 +12.6%
2017-10-10 23:21 2017-10-10 RYTM RHYTHM PHARMACEUTICALS, INC. ORBIMED ADVISORS LLC 10% owner Pharmaceutical Preparations BUY $17.00 355,000 $6,035,000 2,901,295 +13.9%
2017-10-10 16:40 2017-10-10 RYTM RHYTHM PHARMACEUTICALS, INC. Flynn James E 10% owner, Other Pharmaceutical Preparations BUY $17.00 355,000 $6,035,000 468,505 +312.8%
2017-10-10 23:33 2017-10-10 RYTM RHYTHM PHARMACEUTICALS, INC. BARRIS PETER J 10% owner Pharmaceutical Preparations BUY $17.00 550,000 $9,350,000 4,909,956 +12.6%
2017-10-07 00:00 2017-10-06 NLNK N/A Stine Seed Farm, Inc. 10% owner Other BUY $10.25 780,487 $7,999,992 7,857,732 +11.0%
2017-10-06 22:58 2017-10-05 RYTM RHYTHM PHARMACEUTICALS, INC. BAKER BROS. ADVISORS LP Other Pharmaceutical Preparations BUY $17.00 885,000 $15,045,000 1,878,242 +89.1%
2017-10-06 00:05 2017-09-18 WKHS Workhorse Group Inc. LUKENS JOSEPH THEODORE JR 10% owner Motor Vehicles & Passenger Car Bodies BUY $0.36 6,970,283 $2,500,241 6,189,035 +100.0%
2017-10-06 01:25 2017-10-03 MB N/A Luxor Capital Group, LP 10% owner Other BUY $27.95 341,079 $9,532,237 415,702 +457.1%
2017-10-05 23:38 2017-10-04 GEC N/A Drapkin Matthew A Director Other BUY $3.61 1,266,000 $4,572,286 2,402,792 +111.4%
2017-10-06 03:07 2017-10-03 INFI N/A BVF PARTNERS L P/IL 10% owner Other BUY $1.26 1,600,046 $2,008,058 790,583 +100.0%
2017-10-05 23:11 2017-10-03 TDF TEMPLETON DRAGON FUND INC CITY OF LONDON INVESTMENT GROUP PLC 10% owner Other BUY $21.16 100,000 $2,116,000 758,984 +15.2%
SHOW ENTRIES

Institutional Conviction in Form 4

Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.

Filtering the Market Noise

Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.